U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
SEC File No.: 0-22401
CUSIP Number: 09064Q106
(Check One):
|X| Form 10-K
|_| Form 20-F
|_| Form 11-K
|_| Form 10-Q
|_| Form N-SAR
For Period Ended: December 31, 1999
|_| Transition Report on Form 10-K
|_| Transition Report on Form 20-F
|_| Transition Report on Form 11-K
|_| Transition Report on Form 10-Q
|_| Transition Report on Form N-SAR
For the Transition Period Ended: ____________________
- --------------------------------------------------------------------------------
Read Attached Instruction Sheet Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission
has verified any information contained herein.
- --------------------------------------------------------------------------------
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:
- --------------------------------------------------------------------------------
Part I -- Registrant Information
Full Name of Registrant Bionx Implants, Inc.
Former Name if Applicable
Address of Principal Executive Office (Street and Number)
1777 Sentry Parkway West
Gwynedd Hall, Suite 400
City, State and Zip Code Blue Bell, Pennsylvania 19422
Part II -- Rules 12b-25(b) and (c)
If the subject report could not be filed without unreasonable effort
or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate)
|X| (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
|X| (b) The subject annual report, semi-annual report, transition report on
Forms 10-K, 20-F, 11-K or Form N-SAR, or portion thereof, will be filed on
or before the fifteenth calendar day following the prescribed due date; or
the subject quarterly report or transition report on Form 10-Q, or portion
thereof, will be filed on or before the fifth calendar day following the
prescribed due date; and
|_| (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
Part III -- Narrative
State below in reasonable detail the reasons why Forms 10-K, 20-F,
11-K, 10-Q, N-SAR, or the transition report, or portion thereof, could not be
filed within the prescribed time period. (Attach Extra Sheets if Needed)
Bionx Implants, Inc. will be unable to timely file its Annual Report
on Form 10-K for the year ended December 31, 1999 because its
financial statements are not yet available.
Part IV -- Other Information
(1) Name and telephone number of person to contact in regard to this
notification.
Laura R. Kuntz, Esq. (973) 597-2500
(attorney to and authorized
representative of Bionx Implants, Inc.)
- --------------------------------------------------------------------------------
(Name and Title) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Sections 13 or
15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such shorter period
that the registrant was required to file such report(s) been filed? If answer is
no, identify report(s). |X| Yes |_| No
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report or
portion thereof? |X| Yes |_| No
If so: attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
Bionx Implants, Inc. anticipates that its results of operations for
1999 will reflect a loss, while the 1998 year-end financial statements reflected
net income. Until the financial statements are finalized, the amount of the 1999
loss cannot be accurately quantified.
Bionx Implants, Inc.
- --------------------------------------------------------------------------------
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Date: March 30, 1999 By: /s/ Laura R. Kuntz
Name: Laura R. Kuntz
Title: Authorized Representative
of Bionx Implants, Inc.
- ----------------------------------ATTENTION-------------------------------------
Intentional misstatements or omissions of fact constitute Federal
Criminal Violations (See 18 U.S.C. 1001)
- --------------------------------------------------------------------------------
<PAGE>
BIONX IMPLANTS, INC.
TO: Laura R. Kuntz, Esq.
Lowenstein Sandler PC
65 Livingston Avenue
Roseland, New Jersey 07068
FROM: Drew Karazin
Vice President and Chief Financial OFficer
Bionx Implants, Inc.
DATE: March 29, 2000
RE: Form 12b-25
- --------------------------------------------------------------------------------
This memorandum authorizes you to serve as Bionx Implants' authorized
representative for the purpose of completing, signing, and filing Form 12b-25
with the SEC with respect to Bionx's Annual Report on Form 10-K for the year
ended December 31, 1999.
